首页DVAI34 • BVMF
add
德维特
昨日收盘价
R$759.00
当日价格范围
R$766.82 - R$766.82
年度波幅
R$546.63 - R$835.50
市值
103.14亿 USD
平均交易量
14.00
市盈率
-
股息率
-
相关资讯
财务信息
损益表
收入
净收入
| (USD) | 2025年12月info | 年同比变化 |
|---|---|---|
收入 | 36.20亿 | 9.87% |
经营支出 | 6.59亿 | 11.97% |
净收入 | 2.34亿 | -9.68% |
净利润率 | 6.47 | -17.79% |
每股收益 | 3.40 | 51.79% |
息税折旧摊销前利润 | 7.38亿 | 12.69% |
有效税率 | 20.05% | — |
资产负债表
总资产
负债总额
| (USD) | 2025年12月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 7.01亿 | -17.17% |
总资产 | 174.80亿 | 1.13% |
负债总额 | 163.22亿 | 7.42% |
权益总额 | 11.58亿 | — |
发行在外的股份 | 6680.00万 | — |
市净率 | -79.89 | — |
资产回报率 | 7.87% | — |
资本回报率 | 9.79% | — |
现金流
现金净变动
| (USD) | 2025年12月info | 年同比变化 |
|---|---|---|
净收入 | 2.34亿 | -9.68% |
来自运营的现金 | 5.41亿 | -1.26% |
投资现金 | -1.63亿 | 34.22% |
融资现金 | -4.15亿 | 26.65% |
现金净变动 | -3766.70万 | 86.49% |
自由现金流 | 3.96亿 | 16.37% |
简介
DaVita Inc., incorporated in Delaware and headquartered in Denver, provides kidney dialysis services through a network of 2,657 outpatient centers in the United States, serving 200,500 patients, and 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs.
The company is ranked 331st on the Fortune 500. Wikipedia
CEO
成立时间
1992
员工数量
78,000